Entering text into the input field will update the search result below

DARA Biosciences Q4 and FY14 results

  • DARA Biosciences (DARA -12%) Q4 results: Revenues: $0.7M (+999%); Operating Expenses: $2.4M (-7.7%); Net Loss: ($1.6M) (+33.3%).
  • FY2014 results: Revenues: $1.9M (+375.0%); Operating Expenses: $11.3M (+3.7%); Net Loss: ($9M) (+10.0%); Quick Assets: $12.1M (+255.9%).
  • No guidance given.

Recommended For You

More Trending News

About BDRX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
BDRX--
Biodexa Pharmaceuticals Plc